Related Image: Caterpillar Logistics Services Retirees Win a Preliminary Injunction Providing Them Premium-Free Retiree Healthcare |
(Date:11/21/2008)...21 Innerscope Research(TM), a revo...ing in Emotional Response Measurement,announced ... strengthen the,company,s research and developmen..., The three appointments, who deliver a comb...l as Chief Financial Officer and Vice President of...
(Date:11/21/2008)...ty, Panama - The University of Texas M. D. Anderso...ative effort to eradicate breast cancer in Panama ...s and Research of the Americas today at an event w...s, and Vivian Fernndez de Torrijos, the First Lady...itiative are the U.S. Department of State and Susa...
(Date:11/21/2008)...Nov. 21 Three Minnesotans who succ...ing a special on-ice presentation at,the Minnesot...er. The winners,were participants in The QuitCash...Way Minnesota(SM) and QUITPLAN(R) Services. , ...ash, while two runners-up,will get $1,000 gift ca...
(Date:11/21/2008)...ov. 21 New inventions in computeri... of cognitive disabilities lead fuller,lives, sai...ation. Zimman,presented today at the annual Techn...meeting organized by The National Center for Techn...people with disabilities. , Zimman said cog...
Breaking Medicine News(10 mins):Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2Health News:New Applications for Cognitive Training 2...ers have decoded the genome of a bacteria normally... a deadly heart infection// if it enters the blood...understand the organism, Streptococcus sanguinis, ...for treatment and infection prevention. S. sangu...
...day warned consumers not to use American Bullie A....red// and distributed by T.W. Enterprises, Ferndal...ial to be contaminated with Salmonella, which can ...f there is cross contamination, in people, especia...
...eveloping nations is undermining essential health ...is and malaria// , World Health Organization Direc...pore ahead of World Health Day on April 7. Thousa... left their homes in developing nations in search ...
...ted overwhelmingly to remove Coca-Cola products fr... implemented// unethical practices in India and Co...iversity of Guelph voted last week to remove Coca-...te beverage supplier, according to India Resource ...
Other Medicine News:Health News:Scientists Decode Genome of Oral Pathogen 2(Date:11/20/2008)...A, Calif., Nov. 20 Duska...announced today that it has submitted its,pivotal... under a Special,Protocol Assessment (SPA) proced...DA). , Subject to securing an agreement wit...ospective, double-blind, placebo-controlled and ra...
(Date:11/20/2008)... Nov. 20 PAREXEL Interna...obal biopharmaceutical services provider, today an... to provide regulatory consulting and clinical res...office, PAREXEL now has locations throughout five ...ca, which also include Argentina, Brazil, Chile, a...
(Date:11/19/2008)...D OAKS, Calif., Nov. 19 ...a Oncology Company, a subsidiary of,Takeda Pharma...ced that,enrollment in the Phase 3 MONET1 trial e... paclitaxel and carboplatin for the first-line tre...CLC) has been temporarily suspended,following a p...
(Date:11/19/2008)...HELLE, N.Y., Nov. 19 Biotech scien...ies to toxicology research to better understand th... organ systems, reports Genetic Engineering &...interested in figuring out a new compound,s mechan...ve toxicology technique, according to the November...
Breaking Medicine Technology:Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2ATS Medical Appoints James L Cox M D as Medical Director 8097 1ATS Medical Appoints James L Cox M D as Medical Director 8097 2ATS Medical Appoints James L Cox M D as Medical Director 8097 3ScienceDirect to Host French Language Journals from Elsevier Masson 2144 1ScienceDirect to Host French Language Journals from Elsevier Masson 2144 2ScienceDirect to Host French Language Journals from Elsevier Masson 2144 3Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic 2142 1Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic 2142 2Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic 2142 3Truck safe bamboo bridge opens in China 1551 1...l Show Those Treated with Lumiracoxib,Experienced ...pared,to Ibuprofen, EAST HANOVER, N.J., June 15, 2...ho also have controlled hypertension experienced a...hen treated with,the investigational selective COX...ease in those taking ibuprofen, a commonly-used,no...
...rial show those treated with,Prexige experienced s...ared to ibuprofen[1] , * Many patients with osteoa... changes in blood pressure can impact,cardiovascul...0 countries and currently under,review in US for u..., June 15, 2007 - Patients with osteoarthritis,who...
Other Medicine Technology:Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 6Retrobulbar Needle, 23 g. Atkinson style bevel. Overall length 38 mm. 5/box.
Micro Blade tip 6900 style, straight. Dimensions: 15.2 mm x 2.5 mm x 6.2 mm.
Blade tip handle.
Needle Knife, straight, full handle, non-reflective, 0.74 mm width.
Medicine Products: